Hur, Peter
Kim, Nina
Dai, Dong
Piao, Olivia W.
Zheng, Josh Z.
Yi, Esther
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Accepted: 24 October 2020
First Online: 12 November 2020
Declarations
:
: This study was sponsored by Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. Support for third-party writing assistance for this manuscript, furnished by Meaghan Paganelli, PhD, of Health Interactions, Inc, was provided by Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
: P. Hur, D. Dai, and E. Yi are employees of Novartis Pharmaceuticals Corporation. N. Kim was a postdoctoral fellow at the University of Texas at Austin and Baylor Scott and White Health, providing services to Novartis Pharmaceuticals Corporation, at the time of this study. O. W. Piao was an employee of KMK Consulting, Inc, at the time of this study and is a current employee of Flatiron Health. J. Z. Zheng is an employee of KMK Consulting, Inc, and works as a consultant for Novartis.
: Because the current study used only de-identified patient records and did not involve the collection, use, or transmittal of individually identifiable data, institutional review board approval was not required to conduct this study.
: Not applicable; this retrospective study of claims data used de-identified patient records and did not involve the collection, use, or transmittal of individually identifiable data.
: All data generated or analyzed during this study are included in this published article.
: All authors made substantial contributions to the conception and design, execution, or analysis and interpretation of the data; were involved in drafting and critically revising the manuscript; have given necessary attention to ensure the integrity of the work; have read and approved all versions of this manuscript and its submission; and fulfill the ICMJE guidelines for authorship.